Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Clearbridge Health Ltd. ( (SG:1H3) ) has shared an update.
Clearbridge Health Limited has announced changes to its remuneration committee following the resignation of Non-Executive Non-Independent Chairman Mr. Chen Johnson, effective 27 February 2026, due to his taking up a new role at a professional services firm that raises independence and compliance considerations. The board has expressed appreciation for Mr. Chen’s contributions and confirmed that, from the same date, Mr. Mah How Soon (Ma Haoshun) will join the remuneration committee, which will then comprise chairman Andrew John Lord and members Mark Benedict Ryan and Mah How Soon, ensuring continuity in oversight of executive pay and governance matters.
The most recent analyst rating on (SG:1H3) stock is a Sell with a S$0.01 price target. To see the full list of analyst forecasts on Clearbridge Health Ltd. stock, see the SG:1H3 Stock Forecast page.
More about Clearbridge Health Ltd.
Technical Sentiment Signal: Sell
Current Market Cap: S$8.59M
See more insights into 1H3 stock on TipRanks’ Stock Analysis page.